yemenjmedYemen Journal of MedicinecoVolume 4 Issue 1MultidisciplinaryEnglishJanuary- April 2025NNY20250522ArticleVenous Thromboembolism During Pregnancy and Postpartum: An Updated ReviewEnglishY7994ElmukhtarHabas1EnglishNEshrakHabas2EnglishYAmnnaRayani3EnglishYAlaHabas2EnglishYKhalidAlarbi4EnglishYJamalAlfitori5EnglishYAmlHabas2EnglishYKalifaFarfar6EnglishYAlmehdiErrayes5EnglishYAbdel-NaserElzouki5.EnglishY10.63475/yjm.v4i1.0030Venous thromboembolism (VTE) is a serious medical condition that has a high clinical burden on both the mother and fetus, despite having a low incidence during pregnancy and the postpartum period. VTE is a leading cause of death among pregnant women and new mothers worldwide, and its severity cannot be underestimated. The development of VTE is influenced by a combination of genetic and environmental factors, as well as acquired conditions. Pregnancy-related changes, such as increased levels of coagulation factors and diminished fibrinolysis, can increase the risk of VTE. Additionally, older mothers, those who are obese, multiparous, or have undergone cesarean delivery, are at a higher risk of developing VTE. Owing to the lack of standardized guidelines and reliable data on VTE prevention, diagnosis, and treatment, authorities have developed risk scores that allow for a personalized assessment of the risk of thrombosis during pregnancy and postpartum, enabling a tailored approach to prevent thrombosis. Managing VTE during pregnancy poses significant challenges because the benefits and risks of anticoagulant treatment for both the mother and fetus must be carefully balanced. An interdisciplinary approach that includes obstetricians, neonatologists, physicians, and hematologists is essential to achieving optimal outcomes. This review explored the VTE updates in pathogenesis, presentation, complications, treatment options, and research gaps with proposal strategies to improve VTE outcomes and suggest further research.EnglishVenous thromboembolism (VTE), venous embolism, pregnancy, anticoagulation, Deep vein thrombosis (DVT).https://yemenjmed.com/admin/abstract?id=146References1619Varrias D, Spanos M, Kokkinidis DG, Zoumpourlis P, Kalaitzopoulos DR. Venous Thromboembolism in Pregnancy: Challenges and Solutions. Vasc Health Risk Manag. 2023;19:469-84.Morris JM, Algert CS, Roberts CL. Incidence and risk factors for pulmonary embolism in the postpartum period. J Thromb Haemost. 2010;8(5):998and;ndash;1003.Al-Husban N, Alnsour LN, El-Adwan Z, Saleh NA, El-Zibdeh M.and;nbsp;Impact of Pregnancy-Related Venous Thromboembolism on Quality of Patientsand;#39; Lives. Clin Appl Thromb Hemost. 2021;27:10760296211040873.Kearsley R, Stocks G. Venous thromboembolism in pregnancy-diagnosis, management, and treatment. BJA Educ. 2021;21(3):117-23.Knight M, Bunch K, Tuffnell D, Patel R, Shakespeare J, Kotnis R, Kenyon S, Kurinczuk JJ (Eds.) on behalf of MBRRACE-UK. Saving Lives, Improving Mothersand;#39; Care - Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into.Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA,and;nbsp;et al. Pregnancy-related mortality surveillance--United States, 1991--1999. MMWR Surveill Summ. 2003;52(2):1-8.Pregnancy Mortality Surveillance System. Maternal mortality. CDC. https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm. Accessed December 2024.Baeva S, Saxton DL, Ruggiero K, Kormondy ML, Hollier LM,and;nbsp;et al. Identifying Maternal Deaths in Texas Using an Enhanced Method, 2012. Obstet Gynecol. 2018;131(5):762-769.Blondon M, Harrington LB, Righini M, Boehlen F, Bounameaux H, Smith NL. Racial and ethnic differences in the risk of postpartum venous thromboembolism: a population-based, case-control study. J Thromb Haemost. 2014;12(12):2002and;ndash;2009.Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697-706.James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194:1311-5.Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6:632-7.Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ. Res. 2016;118:1340-47.Hong J, Lee JH, Yhim HY, Choi WI, Bang SM, Lee H, et al. Incidence of venous thromboembolism in Korea from 2009 to 2013. PLoS ONE. 2018;13:e0191897.Danwang C, Temgoua MN, Agbor VN, Tankeu AT, Noubiap JJ. Epidemiology of venous thromboembolism in Africa: a systematic review. J. Thromb. Haemost. 2017;15:1770-81.Lee LH, Gallus A, Jindal R, Wang C, Wu CC. Incidence of Venous Thromboembolism in Asian Populations: A Systematic Review. Thromb Haemost. 2017;117(12):2243-60. doi: 10.1160/TH17-02-0134.Ceresetto JM. Venous thromboembolism in Latin America: a review and guide to diagnosis and treatment for primary care. Clinics. 2016;71:36and;ndash;46.Vand;aacute;zquez FJ, Posadas-Martand;iacute;nez ML, Vicens J, Gonzand;aacute;lez Bernaldo de Quirand;oacute;s F, Giunta DH. Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort. Thrombosis J. 2013;11:16.Arab H, Abduljabbar H, Sabr Y, Bondogji N, Mosali F, Bajouh O, et al. Venous Thrombo prophylaxis in Pregnancy and Puerperium: the Saudi Algorithm. 2017; 2(3): 555590.Ahmed M, Akbar D, Al-Shaikh A. Deep vein thrombosis at King Abdul Aziz University Hospital. Saudi Med J. 2000;21(8):762-4.Sarah A Alharbi et al. Womenand;#39;s Awareness of Risk of DVT During Pregnancy and Puerperium: A Cross Sectional Study in Jeddah. World Family Medicine. 2020; 18(1): 187-193.Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG. 2001;108(1):56and;ndash;60.McColl MD, Ramsay JE, Tait RC, Walker ID, McCall F, Conkie JA,and;nbsp;et al. Risk factors for pregnancy-associated venous thromboembolism. Thromb Haemost. 1997;78(4):1183and;ndash;1188.Kourlaba G, Relakis J, Kontodimas S, Holm MV, Maniadakis N.and;nbsp;A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women. Int J Gynaecol Obstet. 2016;132(1):4and;ndash;10.Bates SM, Rajasekhar A, Middeldorp S, McLintock C, Rodger MA, James AH,and;nbsp;et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317and;ndash;3359.James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005;193(1):216-19.Say L, Chou D, Gemmill A, Tunand;ccedil;alp and;Ouml;, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323-33.Bourjeily G, Paidas M, Khalil H, Rosene-Montella K, Rodger M. Pulmonary embolism in pregnancy. Lancet. 2010;375:500and;ndash;12.Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol. 1997;104:191and;ndash;7.Raia-Barjat T, Edebiri O, Chauleur C. Venous Thromboembolism Risk Score and Pregnancy. Front Cardiovasc Med. 2022;9:863612Rodger M, Sheppard D, Gand;aacute;ndara E, Tinmouth A. Haematological problems in obstetrics. Best Pract Res Clin Obstet Gynaecol. 2015;29:671-84.Boeldt DS, Bird IM. Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia. J Endocrinol. 2017;232(1):27-44.Lim A, Samarage A, Lim BH. Venous thromboembolism in pregnancy. Obstet Gynaecol Reprod Med 2016;26:133-9.Dado C, Levinson A, Bourjeily G. Pregnancy and Pulmonary Embolism. Clin Chest Med. 2018;39(3):525-37.Greer IA. Clinical Practice. Pregnancy complicated by venous thrombosis. N Engl J Med. 2015;373:540-7.Wik HS, Jacobsen AF, Sandvik L, Sandset PM. Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study. J Thromb Haemost. 2012;10(5):840-7.Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperiumand;ndash;a register-based case-control study. Am J Obstet Gynecol. 2008;198:233.Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv. 1999;54:265-71.Tepper NK, Boulet SL, Whiteman MK, Monsour M, Marchbanks PA, Hooper WC, et al. Postpartum venous thromboembolism: incidence and risk factors. Obstet Gynecol. 2014;123:987-96.Kamel H, Navi BB, Sriram N, Hovsepian DA, Devereux RB, Elkind MS. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370(14):1307-15Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S-e736S.Pabinger I, Grafenhofer H, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K, et al. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood. (2002) 100:1060and;ndash;2.Iorio A, Kearon C, Filippucci E, Marcucci M, Macura A, Pengo V, et al.and;nbsp;Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Arch Intern Med. 2010;170:1710-6.De Stefano V, Martinelli I, Rossi E, Battaglioli T, Za T, Mannuccio Mannucci P, Leone G.and;nbsp;The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol. (2006) 135:386-91.Croles FN, Nasserinejad K, Duvekot JJ, Kruip MJ, Meijer K, Leebeek FW. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis. BMJ. 2017;359:j4452.Royal College of Obstetricians and Gynaecologists . vol. 37a. Green-top Guideline; 2015. (Reducing the risk of venous thromboembolism during pregnancy and the puerperium). https://www.rcog.org.uk/media/qejfhcaj/gtg-37a.pdf.Kevane B, Donnelly J, Dand;#39;Alton M, Cooley S, Preston RJ, Nand;iacute; Ainle F.and;nbsp;Risk factors for pregnancy-associated venous thromboembolism: a review. J Perinat Med. 2014;42:417-25.Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost. 2008;6:905-12.Oand;#39;Shaughnessy F, Oand;#39;Reilly D, Nand;iacute; and;Aacute;inle F. Current opinion and emerging trends on the treatment, diagnosis, and prevention of pregnancy-associated venous thromboembolic disease: a review. Transl Res. 2020;225:20-32.National Guideline Alliance (UK). Risk factors for venous thromboembolism in pregnancy: Antenatal care: Evidence review N. London: National Institute for Health and Care Excellence (NICE); 2021 Aug. (NICE Guideline, No. 201.)Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 1999;353(9160):1258-65.Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153-68. doi: 10.1016/s1521-6926(03)00021-5.Dalaker K, Prydz H. The coagulation factor VII in pregnancy. Br J Haematol. 1984;56(2):233-41.Thornton P, Douglas J. Coagulation in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2010;24(3):339-52.Estelland;eacute;s A, Gilabert J, Andrand;eacute;s C, Espaand;ntilde;a F, Aznar J. Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy. Thromb Haemost. 1990;64(2):281-85.Sheu JR, Hsiao G, Lin WY, Chen TF, Chien YY, Lin CH, et al. Mechanisms involved in agonist-induced hyperaggregability of platelets from normal pregnancy. J Biomed Sci. 2002;9(1):17-25.Janes SL, Goodall AH. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in preeclampsia and pregnancy. Clin Sci. 1994;86(6):731-39. doi: 10.1042/cs0860731.Aharon A, Katzenell S, Tamari T, Brenner B. Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications. J Thromb Haemost. 2009;7(6):1047-50.Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J Afr. 2016;27(2):89-94.Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130(12):1003-8.Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol. 1997;104(2):191-7.James AH. Pregnancy-associated thrombosis. Hematology. 2009;2009(1):277-85.Kovacevich GJ, Gaich SA, Lavin JP, Hopkins MP, Crane SS, Stewart J, et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. Am J Obstet Gynecol. 2000;182(5):1089-92.Song G, Kim J, Bazer FW, Spencer TE. Progesterone and interferon tau regulate hypoxia-inducible factors in the endometrium of the ovine uterus. Endocrinology. 2008;149(4):1926-34. doi: 10.1210/en.2007-1530.Abou-Ismail MY, Citla Sridhar D, Nayak L.and;nbsp;Estrogen and thrombosis: a bench to bedside review. Thromb Res. 2020;192:40-51.Chen J, Khalil RA. Matrix metalloproteinases in normal pregnancy and preeclampsia. Prog Mol Biol Transl Sci. 2017;148:87-165.Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol. 1997;73(1):31-6.Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004;114(5-6):409-14.American College of Obstetricians and Gynecologists. ACOG practice bulletin No. 197: inherited Thrombophilias in Pregnancy. Obstet Gynecol. 2018;132(1):e18and;ndash;e34.Ridker PM. Ethnic distribution of factor V Leiden in 4047 men and women. JAMA. 1997;277(16):1305.Mekaj Y, Lulaj S, Daci F, Rafuna N, Miftari E, Hoxha H, et al. Prevalence and role of antithrombin III, protein C and protein S deficiencies and activated protein C resistance in Kosovo women with recurrent pregnancy loss during the first trimester of pregnancy. J Hum Reprod Sci. 2015;8(4):224-9.Pabinger I, Schneider B. Thrombotic risk in hereditary antithrombin III, Protein C, or Protein S deficiency. Arterioscler Thromb Vasc Biol. 1996;16(6):742-8. doi: 10.1161/01.ATV.16.6.742.Makris M. Thrombophilia: grading the risk. Blood. 2009;113(21):5038-9.Zotz RB, Gerhardt A, Scharf RE. Inherited thrombophilia and gestational venous thromboembolism. Best Pract Res Clin Haematol. 2003;16(2):243-59.Khare M, Nelson-Piercy C. Acquired thrombophilias and pregnancy. Best Pract Res Clin Obstet Gynaecol. 2003;17(3):491-507.Lechner K, Pabinger-Fasching I. Lupus anticoagulants and thrombosis. Pathophysiol Haemost Thromb. 1985;15(4):254and;ndash;262.Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332(15):993-7.Branch DW. Antiphospholipid antibodies and pregnancy: maternal implications. Semin Perinatol. 1990;14(2):139-46.Ringrose DK. Anaesthesia and the antiphospholipid syndrome: a review of 20 obstetric patients. Int J Obstet Anesth. 1997;6(2):107-11.Bates SM. Management of pregnant women with thrombophilia or a history of venous thromboembolism. Hematology. 2007;2007(1):143-50.Chan WS, Spencer FA, Ginsberg JS. Anatomic distribution of deep vein thrombosis in pregnancy. CMAJ. 2010;182(7):657-60.Hull RD, Raskob GE, Carter CJ. Serial impedance plethysmography in pregnant patients with clinically suspected deep-vein thrombosis. Clinical validity of negative findings. Ann Intern Med. 1990;112(9):663and;ndash;667. doi: 10.7326/0003-4819-112-9-663.Touhami O, Marzouk SB, Bennasr L, Touaibia M, Souli I, Felfel MA, Kehila M, et al. Are the Wells Score and the Revised Geneva Score valuable for the diagnosis of pulmonary embolism in pregnancy? Eur J Obstet Gynecol Reprod Biol. 2018;221:166-71.Chan WS, Rey E, Kent NE; VTE in Pregnancy Guideline Working Group, et al. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014;36(6):527-53.Dronkers CE, Srand;aacute;mek A, Huisman MV, Klok FA. Accurate diagnosis of iliac vein thrombosis in pregnancy with magnetic resonance direct thrombus imaging (MRDTI). BMJ Case Rep. 2016;2016.To MS, Hunt BJ, Nelson-Piercy C. A negative D-dimer does not exclude venous thromboembolism (VTE) in pregnancy. J Obstet Gynaecol. 2008;28(2):222-3.Simcox LE, Ormesher L, Tower C, Greer IA. Pulmonary thrombo-embolism in pregnancy: diagnosis and management. Breathe (Sheff) 2015; 11(4):282-9.Gibson PS, Powrie R. Anticoagulants and pregnancy: when are they safe? Cleve Clin J Med. 2009;76(2):113-27.Krivak TC, Zorn KK. Venous thromboembolism in obstetrics and gynecology. Obstet Gynecol. 2007;109(3):761-77.Richter C, Sitzmann J, Lang P, Weitzel H, Huch A, Huch R. Excretion of low molecular weight heparin in human milk. Br J Clin Pharmacol. 2001;52(6):708-10.Greer I, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106(2):401-7.Bates SM, Greer IA, Hirsh J, Ginsberg JS.and;nbsp; Use of antithrombotic agents during pregnancy: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3):627Sand;ndash;644S.Cohen H, Arachchillage DR, Middeldorp S, Beyer-Westendorf J, Abdul-Kadir R. Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14(8):1673-6.Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):e545-e608.Ejaz U, Akhtar F, Xue J, Wan X, Zhang T, He S. Review: Inhibitory potential of low molecular weight Heparin in cell adhesion; emphasis on tumor metastasis. Eur J Pharmacol. 2021;892:173778.Band;uuml;ller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3):401Sand;ndash;428S.Schulman S, Granqvist S, Holmstrand;ouml;m M, Carlsson A, Lindmarker P, Nicol P, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The duration of anticoagulation trial study group. N Engl J Med. 1997;336(6):393-8.Bagaria SJ, Bagaria VB. Strategies for diagnosis and prevention of venous thromboembolism during pregnancy. J Pregnancy. 2011;2011:206858.Middleton P, Shepherd E, Gomersall JC. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2021;3(3):CD001689.Harris SA, Velineni R, Davies AH. Inferior vena cava filters in pregnancy: a systematic review. J Vasc Interv Radiol. 2016;27(3):354and;ndash;60.e8.Pfeifer GW. Distribution and placental transfer of 131-I streptokinase. Australas Ann Med. 1970;19(1):17-8.Holden EL, Ranu H, Sheth A, Shannon MS, Madden BP. Thrombolysis for massive pulmonary embolism in pregnancy--a report of three cases and follow up over a two year period. Thromb Res. 2011;127(1):58-9.te Raa GD, Ribbert LSM, Snijder RJ, Biesma DH. Treatment options in massive pulmonary embolism during pregnancy; a case-report and review of literature. Thromb Res. 2009;124(1):1-5.Bates SM, Middeldorp S, Rodger M, James AH, Greer I. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):92-128.Bukhari S, Fatima S, Barakat AF, Fogerty AE, Weinberg I, Elgendy IY. Venous thromboembolism during pregnancy and postpartum period. Eur J Intern Med. 2022;97:8-17.Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol. 2002;99(1):135-44.Hansen AT, Kesmodel US, Juul S, Hvas AM. Increased venous thrombosis incidence in pregnancies after in vitro fertilization. Hum Reprod. 2014; 29: 611-17 29(3):611-7.Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril. 2012;97(1):95-100.Harris SA, Velineni R, Davies AH. Inferior vena cava filters in pregnancy: a systematic review. J Vasc Interv Radiol. 2016;27(3):354-60.e8.Dresang LT, Fontaine P, Leeman L, King VJ. Venous thromboembolism during pregnancy. Am Fam Physician. 2008;77(12):1709and;ndash;1716.Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al.and;nbsp; Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011 Apr 26;123(16):1788-830.Kalaitzopoulos DR, Panagopoulos A, Samant S, Ghalib N, Kadillari J, Daniilidis A, et al. Management of venous thromboembolism in pregnancy. Thromb Res. 2022;211:106-113.Sousa Gomes M, Guimarand;atilde;es M, Montenegro N. Thrombolysis in pregnancy: a literature review. J Matern Fetal Neonatal Med. 2019;32(14):2418-28.Capstick T, Henry MT. Efficacy of thrombolytic agents in the treatment of pulmonary embolism. Eur Respir J. 2005;26(5):864-74.Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, Meyer G, Perrier A. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015;36(10):605-14.Martillotti G, Boehlen F, Robert-Ebadi H, Jastrow N, Righini M, Blondon M. Treatment options for severe pulmonary embolism during pregnancy and the postpartum period: a systematic review. J Thromb Haemost. 2017;15(10):1942-50.Kalaitzopoulos DR, Panagopoulos A, Samant S, Ghalib N, Kadillari J, Daniilidis A, Samartzis N, et al. Management of venous thromboembolism in pregnancy. Thromb Res. 2022;211:106-13.Monteleone PP, Rosenfield K, Rosovsky RP.and;nbsp; Multidisciplinary pulmonary embolism response teams and systems. Cardiovasc Diagn Ther. 2016;6(6):662-7.Bannow SB, Federspiel JJ, David E. Abel, Logan Mauney L, Rachel P. Rosovsky RP, Bates SM. Multidisciplinary care of the pregnant patient with or at risk for venous thromboembolism: a recommended toolkit from the Foundation for Women and Girls with Blood Disorders Thrombosis Subcommittee. Journal of Thrombosis and Haemostasis. 2023;21(6):1432-1440.Brill-Edwards P, Ginsberg JS, Gent M, Hirsh J, Burrows R, Kearon C, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med. 2000;343(20):1439-44.Pabinger I, Grafenhofer H, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K, et al. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood. 2002;100(3):1060-2.Lindqvist PG, Bremme K, Hellgren M. Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism. Acta Obstet Gynecol Scand. 2011;90(6):648-53.Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2004;140(3):175-83.Stephenson ML, Serra AE, Neeper JM, Caballero DC, McNulty J. A randomized controlled trial of differing doses of postcesarean enoxaparin thromboprophylaxis in obese women. J Perinatol. 2016;36(2):95-9.Rodger M. Pregnancy and venous thromboembolism: and;quot;TIPPSand;quot; for risk stratification. Hematology Am Soc Hematol Educ Program. 2014;2014(1):387-92.De Stefano V, Martinelli I, Rossi E, Battaglioli T, Za T, Mannuccio Mannucci P, et al. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol. 2006;135(3):386-91.https://www.aagbi.org/sites/default/files/rapac_2013_web.pdf. Accessed March 2024.Leffert L, Butwick A, Carvalho B. The Society for Obstetric Anesthesia and Perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants. Anesth Analg. 2018;126:92.Working Party:; Association of Anaesthetists of Great Britain and;amp; Ireland; Obstetric Anaesthetistsand;#39; Association; Regional Anaesthesia UK. Regional anaesthesia and patients with abnormalities of coagulation: the Association of Anaesthetists of Great Britain and;amp; Ireland The Obstetric Anaesthetistsand;#39; Association Regional Anaesthesia UK. Anaesthesia. 2013 Sep;68(9):966-72.Yentis SM, Lucas DN, Brigante L. Safety guideline: neurological monitoring associated with obstetric neuraxial block 2020: a joint guideline by the Association of Anaesthetists and the Obstetric Anaesthetistsand;#39; Association. Anaesthesia. 2020;75:913-9.